Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0740
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $12.77 million as of April 16, 2026. Its market cap has decreased by -12.81% in one year.
Market Cap
12.77M
Enterprise Value
10.46M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has decreased from 14.08M to 12.77M, a decrease of -9.27%. That is a compound annual growth rate of -0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 12.77M | 64.44% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 23.07M |
| Anebulo Pharmaceuticals | 20.39M |
| Oncotelic Therapeutics | 15.79M |
| Zeo ScientifiX | 15.55M |
| EOM Pharmaceuticals Holdings | 15.03M |
| HOOKIPA Pharma | 14.66M |
| Finch Therapeutics Group | 12.24M |
| TRON Group | 9.57M |